Trials / Sponsors / Kecellitics Biotech Company Ltd
Kecellitics Biotech Company Ltd
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Immunotherapy With CD19 CAR T-cells for B-Cell Leukemia Leukemia | Phase 1 | 2023-02-01 |
| Unknown | Safety and Efficacy of Sequential CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Lymphoma Lymphoma, B-Cell | Phase 1 / Phase 2 | 2022-12-10 |
| Unknown | Immunotherapy With CD22 CAR T-cells for B-Cell Lymphoma, ALL and CLL Leukemia, Lymphoma | Phase 1 / Phase 2 | 2020-02-01 |